HOUSTON, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in…
THE WOODLANDS, Texas, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will ring the…
January 16, 2026 16:05 ET | Source: Context Therapeutics Inc. PHILADELPHIA, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc.…
January 16, 2026 16:05 ET | Source: CAMP4 Therapeutics CAMBRIDGE, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”…
January 16, 2026 16:15 ET | Source: Zenas BioPharma WALTHAM, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc.…
January 16, 2026 17:05 ET | Source: Annexon Biosciences BRISBANE, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq:…
CHASKA, Minn., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and…
January 16, 2026 16:30 ET | Source: Cellyan Biotechnology Co., Ltd HONG KONG, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Cellyan…
January 02, 2026 16:05 ET | Source: Terns Pharmaceuticals, Inc. FOSTER CITY, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Terns…
January 02, 2026 17:00 ET | Source: Intelligent Bio Solutions, Inc. NEW YORK, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Intelligent…